Botulinum toxin type A in prophylactic treatment of migraine

American Journal of Therapeutics

Volumn 13, Issue 3, 2006, Pages 183-187

  Anand, K S ^a   Prasad, Atul ^b   Singh, M M ^b   Sharma, Sangeeta ^b   Bala, Kiran ^b  

^a DR RAM MANOHAR LOHIA HOSPITAL   (India)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Botulinum toxin type A; Efficacy; Headache; Migraine; Prophylaxis; Quality of life; Tolerability

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENERGY; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOCIAL INTERACTION; SYMPTOMATOLOGY; TREATMENT DURATION; WORK CAPACITY;

ADULT; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 33745832295     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000212705.79248.74     Document Type: Article

References (14)

1. Dodick DW. Botox in the prophylaxis of migraine and headache. Asia Neurotoxin Forum. 2003;6-8.
2. Mathew NT, Kailasam J, Meadors L. Prophylaxis of migraine, transformed, and cluster headache with topira-mate. Headache. 2002;42:796-803.
3. Sharma S, Prasad A, Nehru R, et al. Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine. Headache. 2002;42:896-902.
4. Tabone BN. Botulinum toxin in pain and headache management. J Pharm Care Pain Symptom Control. 2000;819-826.
5. Evers S, Rahman A, Vollmer-Haase J, et al. Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria. Cephalalgia. 2002;22:699-710.
6. Silberstein S, Mathew N, Saper J, et al. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000;40:455-450.
7. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. First edition. Cephalalgia. 1991;11:1-12.
8. Hartmaier SL, Santanello NC, Epstein RS, et al. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache. 1995;35:320-329.
9. Santanello NC, Hartmaier SL, Epstein RS, et al. Validation of new Quality of Life Questionnaire for Acute Migraine. Headache. 1995;35:330-337.
10. Smuts JA, Baker MK, Smuts HM, et al. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol. 1999;6(Suppl 4):S99-S102.
11. Burch CM, Kokoska MS, Glaser DA, et al. Treatment of frontal tension headaches with botulinum toxin A. Cephalalgia. 2001;21:486-491.
12. Porta M. Botulinum toxin type A injections for myofascial pain syndrome and tension type headache. Eur J Neurol. 1999;6(Suppl 4):S103-S109.
13. Lipton RB, Amalnick JC, Ferrari MD, et al. Migraine: identifying and removing barriers to care. Neurology. 1994;44(Suppl 4):63-68.
14. Deyo RA. Measuring functional outcomes in therapeutic trials for chronic diseases. Control Clin Trials. 1984;5:223-240.